Effect of Nano-curcumin versus not receiving it on serum levels of Betatrophin and Irisin in patients with metabolic syndrome

Phase 2

• Conditions: Metabolic syndrome.; Metabolic syndrome; E88.81

• Registration Number: IRCT20120215009014N214
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age: 18 to 70 years old
Metabolic syndrome diagnosis

Exclusion Criteria

Diabetes
Thyroid disease
Liver disease
Renal disease
Using interfering drugs with carbohydrate and lipid metabolism

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measuring the serum levels of Betatrophin. Timepoint: Before intervention and 2 months later. Method of measurement: Through the laboratory test.;Measuring the serum levels of Irisin. Timepoint: Before intervention and 2 months later. Method of measurement: Through the laboratory test.